Negative cognitive styles as risk factors for the occurrence of PMS and PMDD

References

• Alloy, L. B., Abramson, L. Y., Safford, S. M., & Gibb, B. E. (2006). The Cognitive Vulnerability To Depression (CVD) project: Current findings and future directions. In L. B. Alloy & J. H. Riskind (Eds.), Cognitive vulnerability to emotional disorders (pp. 33–62). London: Lawrence Erlbaum Associates, Publishers.
   Google Scholar
• APA. (2013). Diagnostic and statistical manual of mental disorder (5th ed.). Washington, DC: American Psychiatric Publishing.
   Google Scholar
• Bäckström, T., Andréen, L., Björn, I., Johansson, I.-M., & Löfgren, M. (2007). The role of progesterone and GABA in PMS/PMDD. In P. M. S. O’Brien, A. J. Rapkin, & P. J. Schmidt (Eds.), The Premenstrual Syndromes: PMS and PMDD (pp. 117–120). London: Informa Healthcare.
   Google Scholar
• Beckham, E. E., Leber, W. R., Watkins, J. T., Boyer, J. L., & Cook, J. B. (1986). Development of an instrument to measure Beck’s cognitive triad: The cognitive triad inventory. Journal of Consulting and Clinical Psychology, 54(4), 566–567.
   PubMed Web of Science ®Google Scholar
• Blake, F. (1995). Cognitive therapy for premenstrual syndrome. Cognitive and Behavioral Practice, 2, 167–185.
   Web of Science ®Google Scholar
• Chrousos, G. P., Torpy, D. J., & Gold, P. W. (1998). Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: Clinical implications. Annals of Internal Medicine, 129, 229–240.
   PubMedGoogle Scholar
• Deecher, D., Andree, T. H., Sloan, D., & Schechter, L. E. (2008). From menarche to menopause: Exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology, 33, 3–17.
   PubMed Web of Science ®Google Scholar
• Derry, P. A., & Kuiper, N. A. (1981). Schematic prcessing and self-reference in clinical depression. Journal of Abnormal Psychology, 90(4), 286–297.
   PubMed Web of Science ®Google Scholar
• Drosdzol, A., Nowosielski, K., Skrzypulec, V., & Plinta, R. (2011). Premenstrual disorders in polish adolescent girls: Prevalence and risk factors. Journal of Obstetrics and Gynaecology Research, 37(9), 1216–1221.
   PubMed Web of Science ®Google Scholar
• Ferree, N. K., & Cahill, L. (2009). Post-event spontaneous intrusive recollections and strength of memory for emotional events in men and women. Consciousness and Cognition, 18, 126–134.
   PubMed Web of Science ®Google Scholar
• Figueiredo, H. F., Dolgas, C. M., & Herman, J. P. (2002). Stress activation of cortex and hippocampus is modulated by sex and stage of estrus. Endocrinology, 143, 2534–2540.
   PubMed Web of Science ®Google Scholar
• Freeman, E. W. (2003). Premenstrual syndrome and premenstrual dysphoric disorder: Definitions and diagnosis. Psychoneuroendocrinology, 28, 25–37.
   PubMed Web of Science ®Google Scholar
• Freeman, E. W., Kroll, R., Rapkin, A. J., Pearlstein, T., Brown, C., Parsey, K., … Foegh, M. (2001). Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. Journal of Women’s Health & Gender-Based Medicine, 10(6), 561–569.
   PubMedGoogle Scholar
• Gotlib, I. H., & Krasnoperova, E. (1998). Biased information processing as a vulnerability factor for depression. Behavior Therapy, 29, 603–617.
   Web of Science ®Google Scholar
• Graham, C. A., & Sherwin, B. B. (1992). A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. Journal of Psychosomatic Research, 36(3), 257–266.
   PubMed Web of Science ®Google Scholar
• Halbreich, U. (2003). The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology, 28, 55–99.
   Web of Science ®Google Scholar
• Halbreich, U., Borenstein, J., Pearlstein, T., & Kahn, L. S. (2003). The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology, 28, 1–23.
   PubMed Web of Science ®Google Scholar
• Hammen, C. (1997). Depression. Hove: Psychology Press Ltd. Publishers.
   Google Scholar
• Hecker von, U., & Sędek, G. (1999). Uncontrollability, depression, and the construction of mental models. Journal of Personality and Social Psychology, 77(4), 833–850.
   PubMed Web of Science ®Google Scholar
• Indusekhar, R., Usman, S. B., & O’Brien, P. M. S. (2007). Psychological aspects of premenstrual syndrome. Best Practice & Research Clinical Obstetrics and Gynaecology, 21(2), 207–220.
   PubMed Web of Science ®Google Scholar
• Ingram, R. E., Miranda, J., & Segal, Z. (2006). Cognitive vulnerability to depression. In L. B. Alloy & J. H. Riskind (Eds.), Cognitive vulnerability to emotional disorders (pp. 63–91). London: Lawrence Erlbaum Associates, Publishers.
   Google Scholar
• Ingram, R. E., & Ritter, J. (2000). Vulnerability to depression: Cognitive reactivity and parental bonding in high-risk individuals. Journal of Abnormal Psychology, 109(4), 588–596.
   PubMed Web of Science ®Google Scholar
• Kaniasty, K. (2003). Klęska żywiołowa czy katastrofa społeczna? Psychologiczne konsekwencje polskiej powodzi 1997 roku. Gdańsk: Gdańskie Wydawnictwo Psychologiczne.
   Google Scholar
• Kaur, G., Gonsalves, L., & Thacker, H. L. (2004). Premenstrual dysphoric disorder: A review for the treating practitioner. Cleveland Clinic Journal of Medicine, 71(4), 303–321.
   PubMed Web of Science ®Google Scholar
• Kirschbaum, C., Kudelka, B. M., Gaab, J., Schommer, N. C., & Hellhammer, D. H. (1999). Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosomatic Medicine, 61, 154–162.
   PubMed Web of Science ®Google Scholar
• Kirschbaum, C., Pirke, K.-M., & Hellhammer, D. H. (1995). Preliminary evidence for reduced cortisol responsivity to psychological stress in women using oral contraceptive medication. Psychoneuroendocrinology, 20(5), 509–514.
   PubMed Web of Science ®Google Scholar
• Kirschbaum, C., Platte, P., Pirke, K.-M., & Hellhammer, D. (1996). Adrenocortical activation following stressful exercise: further evidence for attenuated free cortisol responses in women using oral contraceptives. Stress Medicine, 12(3), 137–143.
   Google Scholar
• Kornstein, S. G., Harvey, A. T., Rush, A. J., Wisniewski, S. R., Trivedi, M. H., Svikis, D. S., … Harley, R. (2005). Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression. Psychological Medicine, 35, 683–692.
   PubMed Web of Science ®Google Scholar
• Lokuge, S., Frey, B. N., Foster, J. A., Soares, C. N., & Steiner, M. (2011). Depression in women: Windows of vulnerability and new insights into the link between estrogen and serotonin. Journal of Clinical Psychiatry, 72(11), e1563–e1569.
   PubMedGoogle Scholar
• Maruszewski, T. (2002). Psychologia poznania. Gdańsk: Gdańskie Wydawnictwo Psychologiczne.
   Google Scholar
• Miranda, J., Persons, J. B., & Byers, C. N. (1990). Endorsement of dysfunctional beliefs depends on current mood state. Journal of Abnormal Psychology, 99(3), 237–241.
   PubMed Web of Science ®Google Scholar
• Miyaoka, Y., Akimoto, Y., Ueda, K., Ujiie, Y., Kametani, M., Uchiide, Y., & Kamo, T. (2011). Fulfillment of the premenstrual dysphoric disorder criteria confirmed using a self-rating questionnaire among Japanese women with depressive disorders. BioPsychoSocial Medicine, 5(5), 1–8.
   PubMedGoogle Scholar
• O’Brien, P. M. S., & Ismail, K. M. K. (2007). History of the premenstrual disorders. In P. M. S. O’Brien, A. J. Rapkin, & P. J. Schmidt (Eds.), The Premenstrual Syndromes: PMS and PMDD (pp. 1–8). London: Informa Healthcare.
   Google Scholar
• Pearlstein, T., & Steiner, M. (2008). Premenstrual dysphoric disorder: Burden of illness and treatment update. Journal of Psychiatry and Neuroscience, 33(4), 291–301.
   PubMed Web of Science ®Google Scholar
• Qian, X., Droste, S. K., Gutièrrez-Mecinas, M., Collins, A., Kersanté, F., Reul, J. M. H. M., & Linthorst, A. C. E. (2011). A rapid release of corticosteroid-binding globulin from the liver restrains the glucocorticoid hormone response to acute stress. Endocrinology, 152, 3738–3748.
   PubMed Web of Science ®Google Scholar
• Rapkin, A. J., & Kuo, J. (2007). Neurotransmitter physiology: The basis for understanding premenstrual syndrome. In P. M. S. O’Brien, A. J. Rapkin, & P. J. Schmidt (Eds.), The Premenstrual Syndromes: PMS and PMDD (pp. 69–82). London: Informa Healthcare.
   Google Scholar
• Riskind, J. H., & Alloy, L. B. (2006). Cognitive vulnerability to emotional disorders: Theory and research design/methodology. In L. B. Alloy & J. H. Riskind (Eds.), Cognitive vulnerability to emotional disorders (pp. 1–32). London: Lawrence Erlbaum Associates, Publishers.
   Google Scholar
• Segal, Z., & Ingram, R. E. (1994). Mood priming and construct activation in test of cognitive vulnerability to unipolar depression. Clinical Psychology Review, 14(7), 663–695.
   Web of Science ®Google Scholar
• Śliwerski, A. (2014). Psychometric properties of the polish version of the Cognitive Triad Inventory (CTI) – Preliminary study. Archives of Psychiatry and Psychotherapy, 1, 47–54.
   Google Scholar
• Steiner, M., Macdougall, M., & Brown, E. (2003). The premenstrual symptoms screening tool (PSST) for clinicians. Archives of Women’s Mental Health, 6, 203–209.
   PubMedGoogle Scholar
• Taylor, L., & Ingram, R. E. (1999). Cognitive reactivity and depressotypic information processing in children of depressed mothers. Journal of Abnormal Psychology, 108(2), 202–210.
   PubMed Web of Science ®Google Scholar
• Ter Horst, J. P., de Kloet, E. R., Schächinger, H., & Oitzl, M. S. (2011). Relevance of stress and female sex hormones for emotion and cognition. Cellular and Molecular Neurobiology, 32(5), 725–735.
   PubMed Web of Science ®Google Scholar
• Yonkers, K. A., & McCunn, K. L. (2007). Comorbidity of premenstrual syndrome and premenstrual dysphoric disorder with other psychiatric conditions. In P. M. S. O’Brien, A. J. Rapkin, & P. J. Schmidt (Eds.), The Premenstrual Syndromes: PMS and PMDD (pp. 49–54). London: Informa Healthcare.
   Google Scholar
• Yonkers, K. A., Pearlstein, T., Fayyad, R., & Gillespie, J. A. (2005). Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase. Journal of Affective Disorders, 85, 317–321.
   PubMed Web of Science ®Google Scholar
• Young, E. A., & Altemus, M. (2004). Puberty, ovarian steroids, and stress. Annales of New York Academy of Sciences, 1021, 124–133.
   PubMed Web of Science ®Google Scholar